Medicare Part D plans may now cover GLP-1 drugs like Wegovy for individuals with a BMI of 27 or higher if they have a diagnosed history of cardiovascular disease.
Mandatory Requirements
The patient must be enrolled in a Medicare plan that provides prescription drug coverage.
A documented history of cardiovascular disease, such as a previous heart attack, stroke, or peripheral arterial disease.
Clinical classification of obesity (BMI 30+) or overweight (BMI 27+) in conjunction with a heart condition.
Policy & Intake Updates
Following new CMS guidance, Medicare Part D plans are now authorized to cover GLP-1 receptor agonists for cardiovascular risk reduction, significantly increasing access to metabolic treatments for seniors.
View Source Verification →